Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about TOMDF Recent news which mentions TOMDF Most Active On The OTC Markets In September – A Look Back As October Comes To A Close October 27, 2022 Tickers ADRNY AKZOY BASFY BLGO Tags ETHE Partner Content JSAIY From Benzinga A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know September 12, 2022 Tickers ABML ADDYY BASFY BFFAF Tags ONEQ OTC Markets Group TOMDF From Benzinga Meet The Company Developing Advanved Blood Tests To Detect Cancer And Other Diseases August 11, 2022 Tickers TOMDF Tags Benzinga All Access Exclusives TOMDF From Benzinga Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength including 5 Day Dosing, 30 Day Dosing And 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim May 02, 2022 Tickers TOMDF Tags Market News Partner Content General From Benzinga Todos Medical Initiates IRB-Waived Tollovid® Market Research Study And Announces 50% Price Reduction Until May 30th, 2022 April 27, 2022 Tickers TOMDF Tags Benzinga Penny Stocks Biotech From Benzinga Todos Medical To Present At The Emerging Growth Conference April 25, 2022 Tickers TOMDF Tags Partner Content Market News General From Benzinga Todos Medical Appoints Philippe Goix As Chief Commercial Officer For Provista Diagnostics April 21, 2022 Tickers TOMDF Tags Press Releases Todos Medical TOMDF From Benzinga Todos Medical Reports 2nd Long COVID Case Study And Launches Website For Physicians And Pediatricians To Indicate Interest In Participating In Tollovid® Long COVID Clinical Study April 20, 2022 Tickers TOMDF Tags General Market News Partner Content From Benzinga Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid® by LGC Group April 20, 2022 Tickers TOMDF Tags TOMDF Todos Medical Press Releases From Benzinga New Study Reportedly Calls Into Question Merck's Ivermectin COVID Off Label Use And May Bolster 3CL Protease Inhibitors Such As Tollovid April 12, 2022 Tickers MRK PFE TOMDF Tags Partner Content Market News General From Benzinga Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate Of Free Sale With Daily And Acute Dosing On The Label April 06, 2022 Tickers TOMDF Tags Todos Medical TOMDF Press Releases From Benzinga Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants April 04, 2022 Tickers TOMDF Tags Partner Content Market News General From Benzinga UPDATE: Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates April 04, 2022 Tickers TOMDF Tags Todos Medical TOMDF Press Releases From Benzinga Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates April 01, 2022 Tickers TOMDF Tags Press Releases TOMDF Todos Medical From Benzinga Todos Medical Reports Case Study Of Patient With Long COVID March 31, 2022 Tickers TOMDF Tags Penny Stocks Benzinga Biotech From Benzinga Billy Blanks® Endorses Todos Medical's Line Of Tollovid® Products March 28, 2022 Tickers TOMDF Tags Press Releases Todos Medical TOMDF From Benzinga Todos Medical To Present At The Proactive One2One Virtual Forum March 17, 2022 Tickers TOMDF Tags TOMDF Todos Medical Press Releases From Benzinga Todos Medical Completes Acquisition Of Key Assets And Intellectual Property From NLC Pharma March 16, 2022 Tickers TOMDF Tags Todos Medical TOMDF Press Releases From Benzinga Todos Medical To Present At The Emerging Growth Conference March 15, 2022 Tickers TOMDF Tags Press Releases Todos Medical TOMDF From Benzinga Todos Medical Appoints Greg Meiselbach As Vice President Of Government Affairs March 08, 2022 Tickers TOMDF Tags General Market News Partner Content From Benzinga These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators February 14, 2022 Tickers BNPQY CYDY EEENF ETHE Tags EEENF Market News SRUUF From Benzinga Benzinga Announces This Week's All Access Guests February 10, 2022 Tickers FBIO JUPW LWLG MDGS Tags Benzinga SURG JUPW From Benzinga Abbott Labs Outlook Cools the Omicron Led Testing Boom January 28, 2022 Tickers ABT CODX LH MRK Tags Partner Content LH General From Benzinga Todos Medical And NLC Pharma Announce Primary And Secondary Endpoints Met In NLC-V-01 Phase 2 Clinical Trial Of Oral Antiviral 3CL Protease Inhibitor Tollovir™ In The Treatment Of Hospitalized COVID-1 January 27, 2022 Tickers TOMDF Tags Press Releases TOMDF Todos Medical From Benzinga Todos Medical Announces Data Lock in Tollovir™ Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients January 24, 2022 Tickers TOMDF Tags General Market News Partner Content From Benzinga PEPPERDINE UNIVERSITY HOSTS THE 22ND ANNUAL CELEBRITY FLAG FOOTBALL CHALLENGE®, PRESENTED BY TODOS MEDICAL'S TOLLOVID® January 19, 2022 Tickers TOMDF Tags Benzinga Penny Stocks Biotech From Benzinga Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies January 18, 2022 Tickers MRK PFE TOMDF Tags Partner Content General Biotech From Benzinga Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022 January 12, 2022 Tickers TOMDF Tags General Partner Content Market News From Benzinga Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir™ on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022 January 11, 2022 Tickers TOMDF Tags Press Releases TOMDF Todos Medical From Benzinga Todos Medical to Present at January 5, 2022 Emerging Growth Conference January 03, 2022 Tickers TOMDF Tags Biotech Benzinga Penny Stocks From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.